Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies (Q30990384)

30 October 2017

Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies (English)

1 reference

30 October 2017

0 references

8

Baha Sibai

1 reference

Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network

30 October 2017

11

object named as

Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units Network

1 reference

30 October 2017

10

Menachem Miodovnik

1 reference

30 October 2017

5

John C Hauth

1 reference

30 October 2017

6

Mark A Klebanoff

1 reference

30 October 2017

Robert W Powers

1

1 reference

30 October 2017

Arun Jeyabalan

2

1 reference

30 October 2017

Rebecca G Clifton

3

1 reference

30 October 2017

Peter Van Dorsten

4

1 reference

30 October 2017

Marshall D Lindheimer

7

1 reference

30 October 2017

Mark Landon

9

1 reference

30 October 2017

language of work or name

English

0 references

publication date

11 October 2010

1 reference

30 October 2017

1 reference

30 October 2017

5

1 reference

30 October 2017

10

1 reference

30 October 2017

e13263

1 reference

Creative Commons CC0 License

30 October 2017

start time

11 October 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted, dedicated to the public domain by copyright holder

0 references

cites work

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a sma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952583

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952583

Trial of Calcium for Preeclampsia Prevention (CPEP): rationale, design, and methods.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952583

Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952583

Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women

14 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013263

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013263

Circulating angiogenic factors and the risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013263

First Trimester Placental Growth Factor and Soluble Fms-Like Tyrosine Kinase 1 and Risk for Preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013263

Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013263

Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia?

21 January 2018

1 reference

12 December 2020

Low-Dose Aspirin to Prevent Preeclampsia in Women at High Risk

1 reference

12 December 2020

Prevention of premature birth

1 reference

12 December 2020

Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia

1 reference

12 December 2020

Angiogenic factors for the prediction of preeclampsia in high-risk women

1 reference

12 December 2020

Circulating angiogenic factors in singleton vs multiple-gestation pregnancies

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0013263

Identifiers

DOI

1 reference

30 October 2017

0 references

1 reference

30 October 2017

1 reference